Shares of LivaNova PLC (NASDAQ:LIVN) were down 2.5% during mid-day trading on Friday . The stock traded as low as $61.02 and last traded at $61.02, with a volume of 539,309 shares trading hands. The stock had previously closed at $62.56.

Separately, Piper Jaffray Cos. restated an “overweight” rating and set a $59.00 price target (down from $61.00) on shares of LivaNova PLC in a research report on Thursday, July 7th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. LivaNova PLC currently has an average rating of “Hold” and a consensus price target of $69.00.

The firm has a 50 day moving average price of $51.39 and a 200-day moving average price of $52.79. The stock’s market capitalization is $2.98 billion.

In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the firm’s stock in a transaction on Tuesday, May 24th. The shares were sold at an average price of $50.07, for a total transaction of $50,070.00. Following the sale, the director now directly owns 64,137 shares in the company, valued at approximately $3,211,339.59. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Hugh M. Morrison sold 3,600 shares of the firm’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $48.00, for a total transaction of $172,800.00. Following the sale, the director now owns 5,215 shares in the company, valued at $250,320. The disclosure for this sale can be found here.

Other hedge funds recently made changes to their positions in the company. Wells Fargo & Company MN bought a new stake in shares of LivaNova PLC during the fourth quarter worth about $30,246,000. Schroder Investment Management Group bought a new stake in shares of LivaNova PLC during the fourth quarter worth about $22,818,000. Principal Financial Group Inc. bought a new stake in shares of LivaNova PLC during the fourth quarter worth about $7,987,000. American International Group Inc. bought a new stake in shares of LivaNova PLC during the fourth quarter worth about $5,731,000. Finally, KBC Group NV bought a new stake in shares of LivaNova PLC during the fourth quarter worth about $4,610,000.

LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. The Company provides solutions for patients, healthcare professionals and healthcare systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.